These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 9209049)

  • 1. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.
    Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H
    J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.
    DeHart HP; Heath HE; Heath LS; LeBlanc PA; Sloan GL
    Appl Environ Microbiol; 1995 Apr; 61(4):1475-9. PubMed ID: 7747966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
    Strandén AM; Ehlert K; Labischinski H; Berger-Bächi B
    J Bacteriol; 1997 Jan; 179(1):9-16. PubMed ID: 8981974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and molecular characterization of a gene homologous to epr (endopeptidase resistance gene) in Staphylococcus aureus.
    Sugai M; Fujiwara T; Komatsuzawa H; SuginakaH
    Gene; 1998 Dec; 224(1-2):67-75. PubMed ID: 9931440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation.
    Tschierske M; Ehlert K; Strandén AM; Berger-Bächi B
    FEMS Microbiol Lett; 1997 Aug; 153(2):261-4. PubMed ID: 9271851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus.
    Thumm G; Götz F
    Mol Microbiol; 1997 Mar; 23(6):1251-65. PubMed ID: 9106216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the Staphylococcal peptidoglycan interpeptide bridge.
    Ehlert K; Tschierske M; Mori C; Schröder W; Berger-Bächi B
    J Bacteriol; 2000 May; 182(9):2635-8. PubMed ID: 10762270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus mutants with increased lysostaphin resistance.
    Gründling A; Missiakas DM; Schneewind O
    J Bacteriol; 2006 Sep; 188(17):6286-97. PubMed ID: 16923896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation.
    Rohrer S; Ehlert K; Tschierske M; Labischinski H; Berger-Bächi B
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9351-6. PubMed ID: 10430946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus.
    Hübscher J; Jansen A; Kotte O; Schäfer J; Majcherczyk PA; Harris LG; Bierbaum G; Heinemann M; Berger-Bächi B
    BMC Genomics; 2007 Sep; 8():307. PubMed ID: 17784943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1.
    Sugai M; Fujiwara T; Akiyama T; Ohara M; Komatsuzawa H; Inoue S; Suginaka H
    J Bacteriol; 1997 Feb; 179(4):1193-202. PubMed ID: 9023202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of three additional femAB-like open reading frames in Staphylococcus aureus.
    Tschierske M; Mori C; Rohrer S; Ehlert K; Shaw KJ; Berger-Bächi B
    FEMS Microbiol Lett; 1999 Feb; 171(2):97-102. PubMed ID: 10077832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation.
    Ehlert K; Schröder W; Labischinski H
    J Bacteriol; 1997 Dec; 179(23):7573-6. PubMed ID: 9393725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.
    Gründling A; Schneewind O
    J Bacteriol; 2006 Apr; 188(7):2463-72. PubMed ID: 16547033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus.
    Henze U; Sidow T; Wecke J; Labischinski H; Berger-Bächi B
    J Bacteriol; 1993 Mar; 175(6):1612-20. PubMed ID: 8383661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
    Maidhof H; Reinicke B; Blümel P; Berger-Bächi B; Labischinski H
    J Bacteriol; 1991 Jun; 173(11):3507-13. PubMed ID: 2045371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus.
    de Jonge BL; Sidow T; Chang YS; Labischinski H; Berger-Bachi B; Gage DA; Tomasz A
    J Bacteriol; 1993 May; 175(9):2779-82. PubMed ID: 8478340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target?
    Kopp U; Roos M; Wecke J; Labischinski H
    Microb Drug Resist; 1996; 2(1):29-41. PubMed ID: 9158720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triton X-100 alters the resistance level of methicillin-resistant Staphylococcus aureus to oxacillin.
    Komatsuzawa H; Sugai M; Shirai C; Suzuki J; Hiramatsu K; Suginaka H
    FEMS Microbiol Lett; 1995 Dec; 134(2-3):209-12. PubMed ID: 8586269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.